The outward premise and Triumph’s own brief for the Tiger Sport 800 are straightforward: giving the already excellent Tiger Sport 660 more grunt and a higher general specification, without ...

Triumph’s original Street Triple RS was always going to be a hard act to follow, but they’ve managed to improve it with a few tasty tweaks. It isn’t a huge leap forward, but its deeper pool ...

Charlie Piccione posted a landmark win in spectacular fashion Saturday at the Hunterdon/Warren/Sussex wrestling championship at Phillipsburg. But it wasn’t just the Warren Hills senior’s on ...

Merk Snack Bar owner Mark Baker announced on social media in late December that he would be closing the Ottawa Street North eatery at the end of January.

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

Summit Therapeutics (NASDAQ:SMMT), a drug developer challenging pharma giant Merck's (NYSE:MRK) dominance in lung cancer, won a new buy recommendation from Truist on Wednesday based on its deal ...

Merck & Co. expects to launch an easier-to-administer version of its blockbuster cancer treatment Keytruda before the end of the year, accelerating the company’s efforts to protect its top ...

Mr. Kennedy has referred clients to the firm in cases claiming injuries from the Gardasil vaccine, a Merck product that is meant to prevent cervical cancer that can be caused by the human ...

In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...

NORTHWEST FLORIDA (WKRG) — Greg Merk has run for the Northwest Florida congressional seat twice before, in 2020 and 2022, but this time, he expects to win. The Pensacolan served 21 years as a ...

The Chinese contract drugmaker will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it said in an exchange filing late Monday. The facility, with a net ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...